SWM
SRNE

Spire Wealth Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Spire Wealth Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20,000
Closed -$40K – 2715
2022
Q2 		$40K Buy
20,000
+5,000
+33% +$8.64K ﹤0.01% 1387
2022
Q1 		$35K Sell
15,000
-60
-0.4% -$187 ﹤0.01% 1599
2021
Q4 		$70K Hold
15,060
– – ﹤0.01% 1564
2021
Q3 		$115K Hold
15,060
– – ﹤0.01% 1144
2021
Q2 		$146K Sell
15,060
-4,500
-23% -$35.8K ﹤0.01% 1059
2021
Q1 		$162K Buy
+19,560
New +$207K ﹤0.01% 1162

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Spire Wealth Management's SRNE Position: Q3 2022 in Review

Spire Wealth Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2022, closing a stake of 20,000 shares — an estimated $40K sold.

Spire Wealth Management first reported a position in SRNE in Q1 2021 and held it in 6 quarters. The position peaked at $162K in Q1 2021. 233 funds tracked by Wall St. Rank hold SRNE as of Q3 2022.

  • Spire Wealth Management reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
  • Spire Wealth Management sold 20,000 Sorrento Therapeutics, Inc. shares in Q3 2022, an estimated $40K.
  • Spire Wealth Management first reported a position in Sorrento Therapeutics, Inc. in Q1 2021 and held it in 6 quarters.
  • Spire Wealth Management's Sorrento Therapeutics, Inc. position peaked at $162K in Q1 2021.
  • 233 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2022.

Based on Spire Wealth Management's 13F filing for Q3 2022, filed 7 Nov 2022.